Dr. Agarwal's Health Care Limited

Healthcare · Healthcare Services

NSE: AGARWALEYE BSE: 544350
₹484.25
Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #9 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Apollo Hospitals Enterprise Limited 114,812 73.1 20.1% 4.2% — 73 0 27
Max Healthcare Institute Limited 89,246 124.3 13.4% -19.5% 0.22% 77 0 26
Fortis Healthcare Limited 57,664 255.5 10.5% -27.5% 0.13% 49 26 6
Global Health Limited 35,830 74.4 13.9% -2.5% 0.04% 74 0 30
Aster DM Quality Care Limited 35,828 205.8 8.8% 2.8% 0.43% 53 0 26
Narayana Hrudayalaya Ltd. 35,199 61.9 17.8% -3.7% 0.26% 66 0 29
Dr. Lal Path Labs Ltd. 33,046 38.4 20.1% -38.0% 0.99% 82 0 88
Krishna Institute of Medical Sciences Limited 29,629 105.1 9.5% -2.3% — 47 0 29
Dr. Agarwal's Health Care Limited (this stock) 15,350 334.0 7.9% -1.3% — 47 0 28

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹15,386 Cr
EV / EBITDA
43.5x
EV / Sales
11.20x
Market cap / Sales
11.17x
Earnings yield
0.30%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 386 Cr, up 22.6% YoY.

↑ Positive
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 17 Cr, up 64.9% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 383 22 17 ₹0.5300
March 31, 2026 348 18 11 ₹0.3300
Dec. 31, 2025 335 20 14 ₹0.4400
Sept. 30, 2025 309 10 5 ₹0.1500
June 30, 2025 302 16 10 ₹0.3200
March 31, 2025 281 34 27 ₹0.8500
Dec. 31, 2024 268 12 8 ₹0.2500

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24
Total income (before exceptional items)386354342316315308278
Operating revenue383348335309302281268
Other income3677132710
Operating expenses287256255240235208203
Operating profit96928069677365
Operating profit margin25.0%26.4%23.9%22.3%22.1%26.1%24.2%
Depreciation58564848444239
Interest19191817192123
Exceptional items, gain / (loss)—-5-1-1-1-3-1
Profit before tax22182010163412
Tax6865584
Net profit171114510278
EPS0.530.330.440.150.320.850.25
Net profit (TTM)46395549———
EPS (TTM)1.451.241.761.57———

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year endedRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)
March 31, 2026 1,293 64 39
March 31, 2025 1,044 39 22

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25
Total income (before exceptional items) — — 1,327†—
Operating revenue — — 1,2931,044
Other income — — 33†—
Operating expenses — — 986†—
Operating profit — — 308†—
Operating profit margin — — 23.8%†—
Depreciation — — 197†—
Interest — — 73†—
Exceptional items, gain / (loss) — — -7†—
Profit before tax — — 6439
Tax — — 25†—
Net profit — — 3922
EPS — — 1.24†—

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25
Operating margin23.8%†—
EBIT margin10.6%†—
PBT margin4.9%3.7%
Net margin3.1%2.1%
Interest coverage1.88x†—
Dividend payout——
Earnings retention——
Current ratio0.99x1.85x
Quick ratio0.82x1.71x
Debt to equity0.04x0.08x
Return on equity2.0%1.1%
Return on assets1.3%0.8%
Return on capital employed5.2%†—
Asset turnover0.44x0.37x

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 321 -167 -173 310 11
March 31, 2025 208 -577 374 183 25

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 2,961 1,991 1,960 9 63 307 309 35 672 54
March 31, 2025 2,837 1,934 1,902 74 72 631 342 56 475 47

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.